CN1085097C - Medicine for treating prostatic hyperplasia - Google Patents

Medicine for treating prostatic hyperplasia Download PDF

Info

Publication number
CN1085097C
CN1085097C CN99123036A CN99123036A CN1085097C CN 1085097 C CN1085097 C CN 1085097C CN 99123036 A CN99123036 A CN 99123036A CN 99123036 A CN99123036 A CN 99123036A CN 1085097 C CN1085097 C CN 1085097C
Authority
CN
China
Prior art keywords
medicine
treatment
prostatic hyperplasia
radix
pulverizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99123036A
Other languages
Chinese (zh)
Other versions
CN1294013A (en
Inventor
马俊杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99123036A priority Critical patent/CN1085097C/en
Publication of CN1294013A publication Critical patent/CN1294013A/en
Application granted granted Critical
Publication of CN1085097C publication Critical patent/CN1085097C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicine preparation for treating prostatic hyperplasia and prostatitis, which is prepared from Chinese crude drugs, such as astragalus root, Chinese angelica root, chicken's gizzard-skin, etc. through preparation technology of washing, drying, pulverizing, granulating, packing, etc. The present invention has the advantages of short course of treatment, quickly taking effect and high curative rate.

Description

The medicine of treatment prostatic hyperplasia
The present invention relates to the field of Chinese medicines, especially a kind of prostatic hyperplasia, prostatitic Chinese medicine preparation of being used for the treatment of.
Prostatic hyperplasia (hypertrophy), prostatitis are common person in middle and old age's andropathys, and cardinal symptom is: urgent micturition, frequent micturition, dysurea.This disease can be brought inconvenience and misery to patient's life.Medicine commonly used at present has " bamboo grove peace ", " QIANLIEKANG ", " prostate disease ", " Prostat " and various Chinese medicine preparation etc.Bad during these curative effect of medication fashions, the course of treatment is often longer, and clinical cure rate is low, and the need that have are month after month taken throughout the year, and curative effect is also not remarkable.Current, this disease sickness rate obviously is the gesture of rising, and a patient hastens forward urgent need good effect, the medicine appearance that cure rate is high the age.
The object of the present invention is to provide a kind of treatment prostatic hyperplasia, prostatitic medicine, its short treating period, instant effect, cure rate height.
Technical scheme of the present invention is: it adopts pure Chinese medicinal preparation, medicine comprises: the Radix Astragali, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Endothelium Corneum Gigeriae Galli, the Rhizoma Atractylodis Macrocephalae, Radix Morindae Officinalis, Rhizoma Corydalis, Radix Notoginseng, Fructus Forsythiae, Hirudo, Olibanum, Herba Taxilli, Myrrha, the Radix Rehmanniae, Radix Aconiti Lateralis Preparata, Squama Manis, Radix Adenophorae (Radix Glehniae), Carapax Trionycis, Gekko Swinhonis, Concha Ostreae, Fructus Arctii, Fructus Aurantii, succinum, Cornu Cervi Degelatinatum, the content of various medicines is respectively: Radix Astragali 1-10% Endothelium Corneum Gigeriae Galli 1-10% Rhizoma Corydalis 1-10% water little molehill 1-10% Radix Angelicae Sinensis 1-10% Rhizoma Atractylodis Macrocephalae 1-10% Radix Notoginseng 1-10% Olibanum 1-10% Rhizoma Chuanxiong 1-5% Radix Morindae Officinalis 1-5% Fructus Forsythiae 1-5% Herba Taxilli 1-5% Myrrha 1-10% gun additioner 1-10% Radix Adenophorae (Radix Glehniae) 1-10% Concha Ostreae 1-10% Radix Rehmanniae 1-10% Squama Manis 1-10% Carapax Trionycis 1-10% Gekko Swinhonis 1-10% succinum 1-10% Fructus Arctii 1-10% Fructus Aurantii 1-10% Cornu Cervi Degelatinatum 1-10%
The present invention is the medicament of making by following preparation technology:
(1) cleans: need clean medical material and wash.
(2) oven dry: all medical materials are dried with equipment.
(3) pulverize: the pulverizing medicinal materials after will drying.
(4) granulate: the medical material of pulverizing is made dissolved granule.
(5) packing: with the medicine weighing and bagging that machines.
Embodiments of the invention:
Embodiment 1 each the explosive component content Radix Astragali 4.5% the membrane of a chicken's gizzard 4.5% corydalis tuber 4.5% water little molehill 4.5% Radix Angelicae Sinensis 4.5% bighead atractylodes rhizome 4.5% pseudo-ginseng 4.5% frankincense 4.5% Ligusticum wallichii 2.5% Morinda officinalis 2.5% capsule of weeping forsythia 2.5% parasitic loranthus 2.5% myrrh 4.5% gun additioner 4.5% the root of straight ladybell 4.5% oyster 4.5% dried rhizome of rehmannia 4.5% pangolin 4.5% turtle shell 4.5% gecko 4.5% amber 4.5% great burdock achene 4.5% Fructus Aurantii 4.5% cornu cerve degelatinatum 4.5% present embodiment preparation technology:
(1) cleans: need clean medical material and wash.
(2) oven dry: all medical materials are dried with equipment.
(3) pulverize: the pulverizing medicinal materials after will drying.
(4) granulate: the medical material of pulverizing is made dissolved granule.
(5) packing:with the medicine weighing and bagging that machines. embodiment two: each the explosive component content Radix Astragali 4% the membrane of a chicken's gizzard 4% corydalis tuber 4% water little molehill 4% Radix Angelicae Sinensis 4% bighead atractylodes rhizome 4% pseudo-ginseng 4% frankincense 4% Ligusticum wallichii 2% Morinda officinalis 2% capsule of weeping forsythia 2% parasitic loranthus 2% myrrh 5% gun additioner 5% the root of straight ladybell 5% oyster 5% dried rhizome of rehmannia 5% pangolin 5% turtle shell 5% gecko 5% amber 5% great burdock achene 5% Fructus Aurantii 5% cornu cerve degelatinatum 5% present embodiment preparation technology is identical with embodiment one. Embodiment three: each the explosive component content Radix Astragali 4.8% the membrane of a chicken's gizzard 4.8% corydalis tuber 4.8% water little molehill 4.8% Radix Angelicae Sinensis 4.8% bighead atractylodes rhizome 4.8% pseudo-ginseng 4.8% frankincense 4.8% Ligusticum wallichii 1% Morinda officinalis 1% capsule of weeping forsythia 1% parasitic loranthus 1% myrrh 4.8% gun additioner 4.8% the root of straight ladybell 4.8% oyster 4.8% dried rhizome of rehmannia 4.8% pangolin 4.8% turtle shell 4.8% gecko 4.8% amber 4.8% great burdock achene 4.8% Fructus Aurantii 4.8% cornu cerve degelatinatum 4.8% present embodiment preparation technology is identical with embodiment one.
This medicine is a hereditary recipe, and the inventor is in clinical practice for many years, and with these powdered medicine treatment prostatic hyperplasia 342 examples, this powder is by name: infirmity must leading to.All case Jun Jing city hospital at county level ultrasound diagnosis are confirmed as prostatic hyperplasia in conjunction with clinical symptoms, and wherein the age reckling is 28 years old, the maximum 76 years old, 54 years old mean age, course of disease 1-3 person 156 examples, 4-10 person's 132 examples, person's 54 examples more than 10 years.
The course of treatment standard: (one) clinical recovery, sings and symptoms all disappears, and does not recur, ultrasound diagnosis, prostatic hyperplasia part almost disappears or recovers normal.
(2) take a turn for the better: symptom and sign disappears substantially, does not have recurrence, ultrasound diagnosis, and hypertrophy is partly dwindled more than 1/2 or 2/3.
After using the treatment of this medicine, stop using without exception other any medicine and therapy are thrown the treatment of " infirmity must leading to " powder, cured person the shortest course of treatment of treatment time, the longest six courses of treatment, average three courses of treatment, clinical cure rate reaches 82%, improvement rate 16%, total effective rate reaches 100%, hypertrophy part is dwindled significantly or recovers normally frequent micturition, urgent micturition, cardinal symptoms such as dysurea disappear thereupon.
Curative effect of the present invention is showed by model case.
Li Zengsheng: 68 years old, the Hongshan District people of Chifeng.1989 at Chifeng City hospital hospitalization prostatic hyperplasia, clinical symptoms: frequent micturition, and urgent micturition, dysurea, it is invalid to take other medicines, changes clothes powder of the present invention in June, 1998, heals entirely after two courses of treatment.
Zhang Yumin: 61 years old, the Songshan District people of Chifeng.Ultrasound diagnosis is diagnosed as prostatic hyperplasia, and it is invalid to take medicines such as " QIANLIEKANG ", uses powder of the present invention instead, recovery from illness two courses of treatment, and it is normal that the ultrasound diagnosis prostate recovers.
Open and send out: 28 years old, the Ning Dixian people of Chifeng.Suffer from prostatitis, take powder symptom one course of treatment of the present invention and subtract greatly, recovery from illness two courses of treatment is followed up a case by regular visits to after 1 year and is not had recurrence.
Guo Yaguang: 30 years old, people from Aohan Banner, Chifeng, gold mine workman.Nineteen ninety-five was once suffered from prostatitis, after take Chinese medicine and western medicine and cure, because underground work toils away, humidity, mining area hospital in 1996 ultrasound diagnosis is diagnosed as prostatic hyperplasia, it is invalid to take a large amount of Chinese medicines and " prostate disease " medicine of etc.ing, rises in August, 1997 and obeys one course of treatment of powder of the present invention, and symptom is clearly better, symptom complete obiteration two courses of treatment, ultrasound diagnosis recover normal.

Claims (2)

1. a Chinese medicine preparation for the treatment of hyperplasia of prostate is characterized in that it is the particle electuary of being made by the material medicine of following percentage by weight: Radix Astragali 1-10% the membrane of a chicken's gizzard 1-10% corydalis tuber 1-10% water little molehill 1-10% Radix Angelicae Sinensis 1-10% bighead atractylodes rhizome 1-10% pseudo-ginseng 1-10% frankincense 1-10% Ligusticum wallichii 1-5% Morinda officinalis 1-5% capsule of weeping forsythia 1-5% parasitic loranthus 1-5% myrrh 1-10% gun additioner 1-10% the root of straight ladybell 1-10% oyster 1-10% dried rhizome of rehmannia 1-10% pangolin 1-10% turtle shell 1-10% gecko 1-10% amber 1-10% great burdock achene 1-10% Fructus Aurantii 1-10% cornu cerve degelatinatum 1-10%.
2. Chinese medicine preparation according to claim 1 is characterized in that it is the medicament of making by following preparation technology:
(1) clean: need clean medical material and wash,
(2) oven dry: all medical materials are dried with equipment,
(3) pulverize: the pulverizing medicinal materials after will drying,
(4) granulate: the medical material of pulverizing is made dissolved granule,
(5) packing: with the medicine weighing and bagging that machines.
CN99123036A 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia Expired - Fee Related CN1085097C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99123036A CN1085097C (en) 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99123036A CN1085097C (en) 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia

Publications (2)

Publication Number Publication Date
CN1294013A CN1294013A (en) 2001-05-09
CN1085097C true CN1085097C (en) 2002-05-22

Family

ID=5282748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99123036A Expired - Fee Related CN1085097C (en) 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia

Country Status (1)

Country Link
CN (1) CN1085097C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI693938B (en) * 2019-06-12 2020-05-21 康品科技有限公司 Use of burdock extract

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790464B2 (en) * 2003-01-16 2004-09-14 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
CN100342888C (en) * 2005-03-14 2007-10-17 庹元斌 Chinese medicine preparation for treating prostatic hyperplasia
CN101579412B (en) * 2008-05-15 2011-04-20 北京北大维信生物科技有限公司 Medicinal composition for treating prostatauxe and preparation method thereof
CN101461841B (en) * 2009-01-09 2011-02-16 黄卫忠 Chinese patent medicine for treating prostatoplasia
CN101647946B (en) * 2009-08-21 2011-10-26 李丹 Hyperplasia-ablating pill for treating prostate hyperplasia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148964A (en) * 1995-10-23 1997-05-07 张克忠 Tongniaoling for diuresis
CN1169308A (en) * 1996-06-29 1998-01-07 郭万启 Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148964A (en) * 1995-10-23 1997-05-07 张克忠 Tongniaoling for diuresis
CN1169308A (en) * 1996-06-29 1998-01-07 郭万启 Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI693938B (en) * 2019-06-12 2020-05-21 康品科技有限公司 Use of burdock extract

Also Published As

Publication number Publication date
CN1294013A (en) 2001-05-09

Similar Documents

Publication Publication Date Title
CN1193775C (en) Rheumatoid disease treating capsule
CN1085097C (en) Medicine for treating prostatic hyperplasia
CN101099794A (en) Medicine for treating rheumatic arthritis and rheumatoid arthritis
CN1103223C (en) Chinese medicine for treating cholecystitis
CN1085099C (en) Medicine for treating thyroid enlargement and thyroidism
CN108543044B (en) Combined medicine for treating acne and application thereof
CN1476884A (en) Inflammation-relieving plaster and its production method
CN104587267A (en) Traditional Chinese medicine composition for treating psoriasis
CN103536815A (en) Traditional Chinese medicinal composition for treating hemorrhoids symptoms
CN101543577A (en) Traditional Chinese medicine composition for curing whelk and preparation method thereof
CN101152497A (en) Traditional Chinese medicine for treating acne in young people
CN1814153B (en) Medicine composition for preventing and treating breast cancer and preparing method
CN1965974A (en) Medicament for treating psoriasis, preparation process and using method thereof
CN103690922A (en) Traditional Chinese medicinal composition for treating polycystic ovarian syndrome and application thereof
CN1240415C (en) Tablets against allergic purpura
CN102078571B (en) Drug for treating early cirrhosis ascites
CN101254256A (en) Clearing blood nourishing heart powder
CN105327121A (en) Traditional Chinese medicine composition for treating female postmenopausal osteoporosis and preparing method thereof
CN1056530C (en) Chinese medicinal herb composition for treating habitual oppilation
CN1085098C (en) Medicine for treating mastoplasia
CN103721188B (en) A kind of injection care drug preventing cerebrovascular sclerosis and preparation method thereof
CN101450133A (en) Medicine for treating abdominopelvic cavity disease postoperative intestinal adhesion
CN101966329A (en) Medicament for treating rash
CN103432358B (en) Medicament for treating psoriasis
CN102018811A (en) Chinese materia medica preparation for treating urticaria

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
BB1A Publication of application
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee